Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Clinical trial NCT05231629 · RECRUITING
Trial details
- NCT number
- NCT05231629
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2027-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.